Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of text processing methods in social media-based signal detection.
Gavrielov-Yusim N, Kürzinger ML, Nishikawa C, Pan C, Pouget J, Epstein LB, Golant Y, Tcherny-Lessenot S, Lin S, Hamelin B, Juhaeri J. Gavrielov-Yusim N, et al. Among authors: juhaeri j. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1309-1317. doi: 10.1002/pds.4857. Epub 2019 Aug 7. Pharmacoepidemiol Drug Saf. 2019. PMID: 31392844
Assessment of dronedarone utilization using US claims databases.
Wu J, Thammakhoune J, Dai W, Koren A, Tcherny-Lessenot S, Wu C, Caubel P, Juhaeri J. Wu J, et al. Among authors: juhaeri j. Clin Ther. 2014 Feb 1;36(2):264-72.e2. doi: 10.1016/j.clinthera.2014.01.002. Epub 2014 Jan 31. Clin Ther. 2014. PMID: 24486334
The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.
Udo R, Tcherny-Lessenot S, Brauer R, Dolin P, Irvine D, Wang Y, Auclert L, Juhaeri J, Kurz X, Abenhaim L, Grimaldi L, De Bruin ML. Udo R, et al. Among authors: juhaeri j. Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:47-55. doi: 10.1002/pds.3841. Epub 2015 Aug 2. Pharmacoepidemiol Drug Saf. 2016. PMID: 26235335
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H; BRACE Special Interest Group. Radawski C, et al. Among authors: juhaeri j. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1233-40. doi: 10.1002/pds.3859. Epub 2015 Oct 12. Pharmacoepidemiol Drug Saf. 2015. PMID: 26456379 Review.
Recommendations for benefit-risk assessment methodologies and visual representations.
Hughes D, Waddingham E, Mt-Isa S, Goginsky A, Chan E, Downey GF, Hallgreen CE, Hockley KS, Juhaeri J, Lieftucht A, Metcalf MA, Noel RA, Phillips LD, Ashby D, Micaleff A; PROTECT Benefit-Risk Group. Hughes D, et al. Among authors: juhaeri j. Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):251-62. doi: 10.1002/pds.3958. Epub 2016 Jan 22. Pharmacoepidemiol Drug Saf. 2016. PMID: 26800458 Free article.
48 results